Compare QMENTA vs icometrix neuroimaging platforms: clinical trial infrastructure vs point-of-care diagnostics. Choose the right solution for MS...
Multi-site neuroimaging trials face protocol drift, QC bottlenecks, and audit gaps. A 2026 look at operational realities and what actually impacts...
QMENTA vs. Flywheel.io: Compare FDA-cleared CNS clinical AI vs. enterprise R&D infrastructure. See which medical imaging platform fits your trial.
QMENTA vs Medidata Rave Imaging: compare AI biomarkers, central review, imaging EDC, and which platform fits your clinical trial.
Veteran CRO executive and investor brings more than 30 years of clinical research leadership and deep pharma networks to the Barcelona-based medical...
Academic imaging facilities face funding cuts, rising data volumes, and infrastructure costs. Learn how to rethink imaging budget management for 2026.
Learn how to integrate AI tools into medical imaging workflows using QMENTA’s cloud platform, including benefits, challenges, and a 3-step SDK...
IBM Watson pioneer Dr. John E. Kelly III shares his perspective on AI adoption barriers, data quality, and the future of AI-enabled neurological...
Discover how the new McDonald criteria use imaging biomarkers such as the Central Vein Sign (CVS) to make earlier, more accurate MS diagnosis